iZafe Group AB (OSTO:IZAFE B) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IZAFE B iZafe Group AB OSTO:IZAFE B
34 GF Score
Price kr0.30
GF Value kr0.43
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is iZafe Group AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:IZAFE B
34GF Score
iZafe Group AB OSTO:IZAFE B
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is iZafe Group AB (OSTO:IZAFE B) Overvalued in 2026?

Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued. The current stock price of kr0.30 is trading 30.7% below its estimated GF Value™ of kr0.43. GuruFocus considers iZafe Group AB to be Possible Value Trap.

Key valuation signals for OSTO:IZAFE B:

  • FFO:
  • GF Value™: kr0.43 vs. price of kr0.30 (30.7% below fair value)
  • GF Score™: 34/100 with 2 warning signs

No single metric tells the full story. See the OSTO:IZAFE B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iZafe Group AB Business Description

Other Exchanges M02:Germany
Address David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a Swedish digital health company that develops medication management technology for home and institutional care. Its flagship product, the Dosell medication dispenser, is a smart device that automatically dispenses prescribed doses at scheduled times, alerts patients when medication is due, and notifies caregivers or relatives if a dose is missed. The company also provides digital platforms and services for remote monitoring and adherence follow-up, including the iZafe Care and PharmaApp offerings. Customers include municipalities, public and private healthcare providers, home care services, and pharmacies, primarily in Sweden and the Nordic region, with expansion into other European markets. Revenue is generated through sales and leasing of dispensing devices, recurring subscription and service fees for monitoring and support, and partnership agreements with healthcare and pharmaceutical stakeholders. The company is listed on Nasdaq First North Growth Market.
34GF Score

Get the complete analysis for OSTO:IZAFE B

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.30
Price
kr0.43
GF Value